RESUMEN
Acute and chronic trigeminal (TG) neuropathies are the cause of considerable distress, with limited treatments available at present. Nociceptive neurons enriched with the vanilloid type 1 receptor (VR1) partake in pain sensation and sensitization in the TG system. While VR1 blockers with anti-nociceptive potential are of substantial medical interest, their use remains limited due to poor selectivity and lack of cell-targeting capabilities. This study describes a methodology for the alleviation of nociception via targeted depletion of VR1 in TG sensory neurons in rats. In cultured TG ganglion neurons, VR1 expression was virtually abolished by lentiviral short hairpin RNA (LV-VR1). By decorating GFP encoding LV (LV-GFP) and LV-VR1 with IgG192 for targeting TG sensory neurons enriched with the p75 neurotrophin receptor (p75NTR), transduction of a reporter GFP and VR1 depletion was achieved after injection of targeted vectors into the whisker pad. In IgG192/LV-VR1-injected rats, the behavioral response to capsaicin exposure as well as Erk 1/2 phosphorylation and VR1 current activation by capsaicin were significantly reduced. This pioneering investigation, thus, provides a proof of principle for a means of attenuating TG nociception, revealing therapeutic potential.
Asunto(s)
Nocicepción/fisiología , Receptores de Factor de Crecimiento Nervioso/metabolismo , Células Receptoras Sensoriales/metabolismo , Canales Catiónicos TRPV/metabolismo , Ganglio del Trigémino/metabolismo , Animales , Capsaicina/administración & dosificación , Células Cultivadas , Femenino , Lentivirus/fisiología , Sistema de Señalización de MAP Quinasas , Proteínas del Tejido Nervioso , ARN Interferente Pequeño/metabolismo , Ratas Wistar , Receptores de Factores de Crecimiento , Canales Catiónicos TRPV/antagonistas & inhibidores , Ganglio del Trigémino/virologíaRESUMEN
PURPOSE: The aim of this study was to evaluate the effect of BAY 57-1293, a helicase-primase inhibitor, on herpes simplex virus type 1 (HSV-1) reactivation in mice and its efficacy on established disease in rabbits. METHODS: BALB/c mice latent for McKrae-strain HSV-1 were reactivated via heat stress, treated with BAY 57-1293, and their corneas were swabbed for virus or the trigeminal ganglia (TG) obtained for quantification of viral DNA. New Zealand white rabbits were infected and treated topically or orally in comparison with trifluridine or valacyclovir. RESULTS: Oral BAY 57-1293 suppressed reactivation in HSV-1-infected mice and reduced the viral load in TG up to four orders of magnitude. In the rabbits, the therapeutic efficacies of topical BAY 57-1293 and trifluridine were similar. Once-daily oral BAY 57-1293 was significantly more effective than valacyclovir and as effective as twice a day topical trifluridine. CONCLUSIONS: BAY 57-1293 may be more effective than valacyclovir, without the cytotoxicity or potential healing retardation seen with trifluridine. Oral BAY 57-1293 may be a substitute for eye drops as an effective treatment for herpetic keratitis and might be useful in treating stromal keratitis and iritis, as well as preventing recurrences of ocular herpes.
Asunto(s)
ADN Helicasas/antagonistas & inhibidores , ADN Primasa/antagonistas & inhibidores , Inhibidores Enzimáticos/uso terapéutico , Queratitis Herpética/tratamiento farmacológico , Piridinas/uso terapéutico , Tiazoles/uso terapéutico , Proteínas Virales/antagonistas & inhibidores , Animales , ADN Viral/química , Femenino , Trastornos de Estrés por Calor/virología , Herpesvirus Humano 1 , Ratones , Ratones Endogámicos BALB C , Conejos , Sulfonamidas , Lágrimas/virología , Ganglio del Trigémino/virología , Esparcimiento de Virus/efectos de los fármacosRESUMEN
An experimental model of rabies was established in the fruit-eating bat species Artibeus jamaicensis. The infections caused by CVS-N2c and CVS-B2c, which are both stable variants of CVS-24, were compared after inoculation of adult bats in the right masseter muscle. CVS-N2c produced neurologic signs of rabies with paresis, ataxia, and inability to fly, while CVS-B2c did not produce neurologic signs. Bats were sacrificed and the distribution of rabies virus antigen was assessed in tissue sections with immunoperoxidase staining. Both viruses spread to the brain stem and bilaterally to the trigeminal ganglia by days 2 to 3. CVS-N2c had disseminated widely in the central nervous system (CNS) by day 4 and had involved the spinal cord, thalamus, cerebellum, and cerebral cortex. CVS-B2c had infected neurons in the spinal cord on day 5 and in the cerebellum, thalamus, and cerebral cortex on day 6. Infected pyramidal neurons of the hippocampus were observed on day 5 in CVS-N2c infection, but infected neurons were never noted in the hippocampus in CVS-B2c infection. CVS-N2c infected many more neurons and more prominently involved neuronal processes than CVS-B2c. CVS-N2c spread more efficiently in the CNS than CVS-B2c. Morphologic changes of apoptosis or biochemical evidence of DNA fragmentation were not observed in neurons with either virus after this route of inoculation. The different neurovirulent properties of these CVS variants in this model were not related to their in vivo ability to induce apoptosis.
Asunto(s)
Quirópteros , Modelos Animales de Enfermedad , Virus de la Rabia/patogenicidad , Rabia/patología , Animales , Antígenos Virales/análisis , Apoptosis , Núcleos Cerebelosos/patología , Núcleos Cerebelosos/virología , Corteza Cerebral/patología , Corteza Cerebral/virología , Femenino , Etiquetado Corte-Fin in Situ , Masculino , Neuronas/patología , Neuronas/virología , Médula Espinal/patología , Médula Espinal/virología , Tálamo/patología , Tálamo/virología , Ganglio del Trigémino/patología , Ganglio del Trigémino/virología , VirulenciaRESUMEN
The effects of the vaccination of neonatal calves with a glycoprotein E (gE)-negative bovine herpesvirus type 1 (BHV-1) were investigated in naïve and passively immunised calves either with the recommended dose or a 5-fold concentrated one. After inoculation (PI), all calves excreted the virus vaccine except three passively immunised calves inoculated with the lower titre. No antibody response could be detected in passively immunised calves, whatever the dose used, and they all became BHV-1 seronegative and remained so after dexamethasone treatment (PDT). Nevertheless, as shown by a gamma-interferon assay, all calves that excreted the vaccine PI developed a cell-mediated immune response and a booster response was observed PDT, suggesting viral reactivation. The vaccine virus was recovered PDT from nasal secretions in two calves and BHV-1 DNA were detected in trigeminal ganglia from five calves belonging to all inoculated groups. The results show that the BHV-1 gE-negative vaccine can establish latency not only in naïve but also in passively immunised neonatal calves after a single intranasal inoculation. Moreover, this study shows for the first time that the gE-negative vaccine, when used in passively immunised calves, can lead to seronegative vaccine virus carriers.
Asunto(s)
Anticuerpos Antivirales/inmunología , Infecciones por Herpesviridae/veterinaria , Herpesvirus Bovino 1/inmunología , Inmunidad Materno-Adquirida , Rinotraqueítis Infecciosa Bovina/prevención & control , Vacunación/veterinaria , Vacunas Marcadoras/inmunología , Vacunas Virales/inmunología , Animales , Bovinos , Línea Celular , Calostro/inmunología , Dexametasona/farmacología , Relación Dosis-Respuesta Inmunológica , Ensayo de Inmunoadsorción Enzimática , Femenino , Infecciones por Herpesviridae/inmunología , Infecciones por Herpesviridae/prevención & control , Herpesvirus Bovino 1/genética , Herpesvirus Bovino 1/crecimiento & desarrollo , Herpesvirus Bovino 1/aislamiento & purificación , Herpesvirus Bovino 1/fisiología , Inmunidad Celular , Inmunización Pasiva , Inmunización Secundaria , Rinotraqueítis Infecciosa Bovina/inmunología , Interferón gamma/sangre , Pruebas de Neutralización , Embarazo , Factores de Tiempo , Ganglio del Trigémino/virología , Vacunas Atenuadas/inmunología , Proteínas del Envoltorio Viral/deficiencia , Proteínas del Envoltorio Viral/genética , Proteínas Virales , Activación Viral/efectos de los fármacos , Latencia del VirusRESUMEN
This study was conducted to investigate the glycoprotein E (gE) antibody response raised after inoculation with a low infectious dose of bovine herpesvirus 1 (BHV-1) in six calves possessing high levels of passive immunity from cows repeatedly vaccinated with gE deleted marker vaccine. Four out of the six calves developed gE antibodies 3-5 weeks after infection, whereas the two other ones remained seronegative to gE. After 5 months of infection, the six calves were treated with dexamethasone. Virus was only re-excreted by the four calves which previously seroconverted against gE. The two other calves became seronegative against BHV-1, 30-32 weeks after infection. A second dexamethasone treatment performed 11 months after infection failed to demonstrate a latent infection in these two calves. Moreover, the lack of identification of a cell-mediated immune response, after the two dexamethasone treatments, and the failure to detect BHV-1 DNA sequences in trigeminal ganglia strongly suggest that these two calves were not latently infected. In conclusion, the presence of high levels of maternal immunity lacking gE antibodies does not prevent latency after infection with a low titre of BHV-1. Moreover, latency is associated with a serological response to gE. These results confirm that the gE deletion is a good marker to identify young calves latently infected with a field virus.
Asunto(s)
Anticuerpos Antivirales/sangre , Enfermedades de los Bovinos/prevención & control , Infecciones por Herpesviridae/veterinaria , Herpesvirus Bovino 1/inmunología , Proteínas del Envoltorio Viral/inmunología , Latencia del Virus , Animales , Antiinflamatorios/uso terapéutico , Bovinos , Enfermedades de los Bovinos/tratamiento farmacológico , Enfermedades de los Bovinos/inmunología , Calostro/inmunología , ADN Viral/análisis , Dexametasona/uso terapéutico , Femenino , Infecciones por Herpesviridae/tratamiento farmacológico , Infecciones por Herpesviridae/prevención & control , Herpesvirus Bovino 1/genética , Herpesvirus Bovino 1/aislamiento & purificación , Inmunidad Materno-Adquirida , Ganglio del Trigémino/virología , Vacunas de Productos Inactivados , Proteínas Virales , Esparcimiento de VirusRESUMEN
It is generally assumed that reactivation of latent herpes simplex virus occurs through initiation of lytic viral gene transcription from the latent viral genome. Thus, antiviral compounds such as acyclovir, whose activation is dependent upon viral thymidine kinase, should be effective in preventing the initial production of infectious virus associated with reactivation. To test this concept, the ability of acyclovir to prevent the production of infectious virus was determined in the murine hyperthermic stress (HS) model of in vivo reactivation. Acyclovir treatment after HS blocked the production of infectious virus within the ganglia. Efficacy was dependent upon the timing of the first post-HS dose and the length of exposure to acyclovir. A single dose administered 6-9 h after HS resulted in >90% reduction in reactivation. Acyclovir administered 12 h after HS resulted in 75% reduction, but there was no effect if treatment was delayed for 18 h after HS.
Asunto(s)
Aciclovir/farmacología , Herpes Simple/fisiopatología , Herpesvirus Humano 1/efectos de los fármacos , Ganglio del Trigémino/virología , Activación Viral/efectos de los fármacos , Replicación Viral/efectos de los fármacos , Aciclovir/uso terapéutico , Animales , Herpes Simple/tratamiento farmacológico , Herpesvirus Humano 1/genética , Herpesvirus Humano 1/fisiología , Hipertermia Inducida , Masculino , Ratones , Estrés Fisiológico , Factores de TiempoRESUMEN
45 patients were observed in the periods of both acute herpes zoster and postherpetic neuralgia (PHN). In most of the patients herpetic eruptions were located in the areas of innervation of the first branch of the trigeminal nerve. In acute period of the disease there were used aciclovir, helepin or alpisarinum, antiherpetic immunoglobulin, deoxyribonuclease, non-narcotic analgetics were used. Of 28 patients residual PHN was observed in 6 cases, delayed PHN (during 3 months)--in 2 patients. The PHN development was characteristic for elderly patients, delayed request for medical care, concomitant diseases, eruptions with hemorrhagic component and secondary pyodermia and considerable residual sensory deficit. In therapy of PHN the most effective drugs were amitriptylin, non-narcotic analgetics, anticonvulsants as well as acupuncture and electroacupuncture. Relief of a typical deafferentation of pain syndrome was achieved by means of ultrasonic destruction of the trigeminal nucleus (one case). Early therapy of acute herpes zoster does not prevent completely PHN development, but it decreased considerably probability of its forming as well as the severity of its course.
Asunto(s)
Terapia por Acupuntura/métodos , Antivirales/uso terapéutico , Herpes Zóster/complicaciones , Herpes Zóster/terapia , Herpes Zóster/virología , Ganglio del Trigémino/virología , Neuralgia del Trigémino/complicaciones , Neuralgia del Trigémino/tratamiento farmacológico , Neuralgia del Trigémino/virología , Enfermedad Aguda , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Traditional herbal medicines with anti-herpes simplex virus type 1 (HSV-1) activity in vivo were examined for their prophylactic effects on recurrent HSV-1 infection in mice. Mice were intradermally infected with HSV-1 in the pinna and recurrent HSV-1 disease was induced by ultraviolet irradiation. Herbal extracts arrested the progression of recurrent HSV-1 disease, reduced the incidence of severe erythema and/or vesicles in the pinna, and/or shortened the period of severe recurrent lesions compared with water-administered mice (P < 0.01 or 0.05). Similarly, the prophylactic treatment of herbal extracts limited the development of recurrent skin lesions induced by stripping with cellophane tape physically. The prophylactic efficacy on recurrence was confirmed by the absence of HSV DNA in the skin lesions. HSV-1 genome was revealed to exist in the trigeminal ganglia but not in the pinna of latently infected mice before stimuli by a nested-polymerase chain reaction assay. After stimuli, HSV-1 genome was detected in both pinna and trigeminal ganglia of latently infected mice administered with water. However, prophylactic treatment decreased the rate of detection of HSV-1 genome in the stimulated pinna. Thus, the herbal extracts exhibited prophylactic efficacy against recurrent HSV-1 disease in mice and modulated the recurrent HSV-1 infection.
Asunto(s)
Herpes Simple/prevención & control , Herpes Simple/terapia , Plantas Medicinales , Animales , Secuencia de Bases , Cartilla de ADN/genética , ADN Viral/genética , ADN Viral/aislamiento & purificación , Femenino , Herpes Simple/virología , Herpesvirus Humano 1/genética , Herpesvirus Humano 1/aislamiento & purificación , Ratones , Ratones Endogámicos BALB C , Reacción en Cadena de la Polimerasa , Recurrencia , Ganglio del Trigémino/virologíaRESUMEN
BACKGROUND: We treated two patients with dendritic keratitis that did not respond to acyclovir (ACV) ointment therapy. Their systemic immune status was normal: however, one patient had a long history of atopic disease and the other had previously undergone topical corticosteroid treatment. HSV-1 was isolated from the patients and inoculated into animals to investigate its viral pathogenicity and latent infection. METHODS: HSV-1 isolates from the patients were tested for drug sensitivity to acyclovir, ganciclovir, idoxuridine, trifluridine, foscarnet and interferon-beta in vitro. In in vivo studies, bilateral corneas of two New Zealand white rabbits and 10 BALB/c mice in each of four groups were infected by the respective viral isolates. The extent of corneal epithelial and/or stromal lesions produced by the viruses was evaluated. The trigeminal ganglial tissues of the mice were examined for viral latent infection by co-culture with Vero cells. RESULTS: Herpetic keratitis in both patients was characterized by prolonged clinical course, succeeded by various types of corneal lesions and ocular complications. In in vitro studies, the two HSV-1 isolates demonstrated cross-resistance to ACV, ganciclovir and/or idoxuridine. Both strains demonstrated weakly virulent corneal epithelial and/or stromal lesions in rabbits and mice. One isolate displayed delayed advent but prolonged course of epithelial lesions in rabbits. The latent infection incidences of the isolates in mice trigeminal ganglia were 6.25% (1/16) and 0% (0/18) respectively. CONCLUSION: Topical immune depression may induce ACV-resistant HSV-1 infection in the cornea, with a prolonged course in association with ocular complications. The prolonged infectious course of the viral isolates in the animal study partially supported the clinical demonstrations in the patient. The existence of latent infection by one ACV-resistant HSV-1 in its animals may indicate the possibility of its recurrence. Trifluridine may be an alternative choice for treating corneal epithelial lesions caused by ACV-resistant HSV-1.